Association of the epithelial–mesenchymal transition (EMT) with cisplatin resistance

by Ashrafizadeh, M., Zarrabi, A., Hushmandi, K., Kalantari, M., Mohammadinejad, R., Javaheri, T., Sethi, G.
Published 2021

MicroRNAs and their influence on the zeb family: Mechanistic aspects and therapeutic applications in cancer therapy

by Ashrafizadeh, M., Ang, H.L., Moghadam, E.R., Mohammadi, S., Zarrin, V., Hushmandi, K., Samarghandian, S., Zarrabi, A., Najafi, M., Mohammadinejad, R., Kumar, A.P.
Published 2021

Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response

by Ashrafizadeh, M, Paskeh, MDA, Mirzaei, S, Gholami, MH, Zarrabi, A, Hashemi, F, Hushmandi, K, Hashemi, M, Nabavi, N, Crea, F, Ren, J, Klionsky, DJ, Kumar, AP, Wang, Y
Published 2023

Role of microRNA/epithelial-to-mesenchymal transition axis in the metastasis of bladder cancer

by Ashrafizadeh, M., Hushmandi, K., Hashemi, M., Akbari, M.E., Kubatka, P., Raei, M., Koklesova, L., Shahinozzaman, M., Mohammadinejad, R., Najafi, M., Sethi, G., Kumar, A.P., Zarrabi, A.
Published 2021

PTEN, a barrier for proliferation and metastasis of gastric cancer cells: From molecular pathways to targeting and regulation

by Ashrafizadeh, M., Najafi, M., Ang, H.L., Moghadam, E.R., Mahabady, M.K., Zabolian, A., Jafaripour, L., Bejandi, A.K., Hushmandi, K., Saleki, H., Zarrabi, A., Kumar, A.P.
Published 2021

Polychemotherapy with curcumin and doxorubicin via biological nanoplatforms: Enhancing antitumor activity

by Ashrafizadeh, M., Zarrabi, A., Hashemi, F., Zabolian, A., Saleki, H., Bagherian, M., Azami, N., Bejandi, A.K., Hushmandi, K., Ang, H.L., Makvandi, P., Khan, H., Kumar, A.P.
Published 2021

Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention

by Mirzaei, S, Paskeh, MDA, Okina, E, Gholami, MH, Hushmandi, K, Hashemi, M, Kalu, A, Zarrabi, A, Nabavi, N, Rabiee, N, Sharifi, E, Karimi-Maleh, H, Ashrafizadeh, M, Kumar, AP, Wang, Y
Published 2023